HIGHLIGHTS
- who: Yu-Xiang Liang and collaborators from the Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People`s Hospital, School of Medicine, South China University of Technology, Guangzhou, China have published the paper: Tumor Suppressor Role and Clinical Significance of the FEV Gene in Prostate Cancer, in the Journal: Disease Markers 2.0 of 21/03/2022
- what: This study investigated FEV mRNA expression as well as assessed its correlation to PCa patient outcomes after prostatectomy from 1993 to 1995 at the Massachusetts General Hospital. This study received approval . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.